Maryam Zarghooni

Maryam Zarghooni

UNVERIFIED PROFILE

Are you Maryam Zarghooni?   Register this Author

Register author
Maryam Zarghooni

Maryam Zarghooni

Publications by authors named "Maryam Zarghooni"

Are you Maryam Zarghooni?   Register this Author

10Publications

193Reads

43Profile Views

Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directions.

Biosens Bioelectron 2017 May 30;91:588-605. Epub 2016 Dec 30.

Laboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, University of Victoria, 3800 Finnerty Rd., Victoria, BC, Canada V8P 2C5; Center for Biomedical Research, University of Victoria, Victoria, Canada; Center for Advanced Materials and Related Technology (CAMTEC), University of Victoria, Victoria, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2016.12.062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323331PMC
May 2017

Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.

Cell Biochem Funct 2014 Dec 28;32(8):683-91. Epub 2014 Nov 28.

Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbf.3072DOI Listing
December 2014

Aurora kinase B is a potential therapeutic target in pediatric diffuse intrinsic pontine glioma.

Brain Pathol 2013 May 11;23(3):244-53. Epub 2012 Oct 11.

Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1750-3639.2012.00633.xDOI Listing
May 2013

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

J Clin Oncol 2010 Mar 8;28(8):1337-44. Epub 2010 Feb 8.

Division of Pathology andHaematology, The Labatt Brain Tumor Research Centre, The Hospital for Sick Children,Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.25.5463
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.25.5463DOI Listing
March 2010

Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III.

Am J Med Genet A 2009 Dec;149A(12):2753-61

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.33134DOI Listing
December 2009

Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Biochem Genet 2006 Apr 28;44(3-4):173-80. Epub 2006 Apr 28.

Department of Biochemistry, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10528-006-9016-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910080PMC
April 2006

An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A.

Biochem Biophys Res Commun 2004 Nov;324(3):1048-52

Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0402219
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2004.09.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918538PMC
November 2004

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.

Clin Biochem 2002 May;35(3):225-31

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0009-9120(02)00292-8DOI Listing
May 2002